Search research articles
Contact Us
Filters
Showing results (51-60 of 130) with videos related to
Page
of 13
Sort By:
Clinical Pharmacology and Therapeutics
|
September 1, 1974
Heparin half-life in normal and impaired renal function
P J Perry, G R Herron, J C King
Journal of Clinical Psychopharmacology
|
February 24, 2001
Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial
P J Perry, B C Lund, T Sanger, et al.
Pharmacotherapy
|
August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men
B C Lund, K A Bever-Stille, P J Perry
Journal of Affective Disorders
|
March 1, 1989
Is DST status associated with depression characteristics?
M J Garvey, C Schaffer, L Schaffer, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1990
Haloperidol plasma levels and acute clinical change in schizophrenia
W Coryell, M Kelly, P J Perry, et al.
The Journal of Clinical Psychiatry
|
September 1, 1994
Plasma clozapine concentrations as a predictor of clinical response: a follow-up study
D D Miller, F Fleming, T L Holman, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 1, 1986
The utility of a single-point dosing protocol for predicting steady-state lithium levels
P J Perry, B Alexander, R A Prince, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1984
Prospective evaluation of two lithium maintenance dose schedules
P J Perry, B Alexander, R A Prince, et al.
Archives of General Psychiatry
|
December 26, 2001
Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach
B C Lund, P J Perry, J M Brooks, et al.
The Journal of Clinical Psychiatry
|
October 1, 1988
Benzodiazepine withdrawal: a review of the evidence
R Noyes, M J Garvey, B L Cook, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 130) with videos related to
Sort By:
Page
of 13
Clinical Pharmacology and Therapeutics
|
September 1, 1974
Heparin half-life in normal and impaired renal function
P J Perry, G R Herron, J C King
Journal of Clinical Psychopharmacology
|
February 24, 2001
Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial
P J Perry, B C Lund, T Sanger, et al.
Pharmacotherapy
|
August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men
B C Lund, K A Bever-Stille, P J Perry
Journal of Affective Disorders
|
March 1, 1989
Is DST status associated with depression characteristics?
M J Garvey, C Schaffer, L Schaffer, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1990
Haloperidol plasma levels and acute clinical change in schizophrenia
W Coryell, M Kelly, P J Perry, et al.
The Journal of Clinical Psychiatry
|
September 1, 1994
Plasma clozapine concentrations as a predictor of clinical response: a follow-up study
D D Miller, F Fleming, T L Holman, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 1, 1986
The utility of a single-point dosing protocol for predicting steady-state lithium levels
P J Perry, B Alexander, R A Prince, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1984
Prospective evaluation of two lithium maintenance dose schedules
P J Perry, B Alexander, R A Prince, et al.
Archives of General Psychiatry
|
December 26, 2001
Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach
B C Lund, P J Perry, J M Brooks, et al.
The Journal of Clinical Psychiatry
|
October 1, 1988
Benzodiazepine withdrawal: a review of the evidence
R Noyes, M J Garvey, B L Cook, et al.
Page
of 13